Other Clinical Trial - Ultrasound Imaging of Fibrotic Tissue

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Status Recruiting

Clinical Trial Summary

This project intends to collect the ultrasonic spectrum information of shoulder and knee joint fibrotic tissue, and use machine learning to study the mechanism of fibrosis tissue ultrasound imaging, and then build a model and finally establish the relationship between joint stiffness and fibrosis formation. In this study, the broadband ultrasound imaging method for joint fibrosis has the potential to create a method for ultrasonic localization, staining and evaluation of joint fibrosis, laying the foundation for the research of new conservative treatment methods and surgical positioning for fibrosis, and for reducing the occurrence of joint fibrosis rate, improve joint function of patients, and return to family and society earlier and better

Clinical Trial Description

n/a

Study Design

Clinical Trial Details

NCT number	NCT05818904
Study type	Observational [Patient Registry]
Source	Peking University Third Hospital
Contact	Buwen Yao, PhD
Phone	15600555851
Email	buwenyao@gmail.com
Status	Recruiting
Phase
Start date	May 1, 2023
Completion date	December 31, 2024

View Details